ConductScience.org, home

Paper908023

Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene.

Barrett JC and 6 others. Cancer Res, 1977. Cited by 73 papers, by iCite.

Cite this record

ConductScience Library. Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene. Papers, record 908023. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/908023

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Temporal acquistion of enhanced fibrinolytic activity by syrian hamster embryo cells following treatment with benzo(a)pyrene.
PubMed
Journal
Cancer Res
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
73
iCite
Relative citation ratio, by iCite
2.55
iCite
Revised in PubMed
2006-11-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Barrett JCJ C
2Crawford BDB D
3Grady DLD L
4Hester LDL D
5Jones PAP A
6Benedict WFW F
7Ts'o POP O

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BenzopyrenesMajor topic
Cell Transformation, NeoplasticMajor topic
FibrinolysisMajor topic
Cells, Cultured
Clone Cells
Culture Media
Fibrin
Sepharose
Time Factors

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 73 citations.

PMIDTitleJournalYearIn PapersSource
21849266Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma.Mol Oncol2011https://conductscience.org/library/papers/21849266PubMed
8248140Automatic enumeration and characterization of heterogeneous clonal progression in cell transformation.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8248140PubMed
7426322Increased ability of ethylnitrosourea-exposed brain cells to survive suspension in agar.Br J Cancer1980https://conductscience.org/library/papers/7426322PubMed
7193044Effect of 12-O-tetradecanoylphorbol-13-acetate on two charateristics of transformation acquired sequentially by ENU-exposed rat brain cells.Br J Cancer1980https://conductscience.org/library/papers/7193044PubMed
7192286Plasminogen activator induction and platelet aggregation by phorbol and some of its derivatives: correlation with skin irritancy and tumor-promoting activity.J Cancer Res Clin Oncol1980https://conductscience.org/library/papers/7192286PubMed
6865945Neoplastic conversion of preneoplastic Syrian hamster cells: rate estimation by fluctuation analysis.Mol Cell Biol1983https://conductscience.org/library/papers/6865945PubMed
6808514Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme.Proc Natl Acad Sci U S A1982https://conductscience.org/library/papers/6808514PubMed
6453346Activation of plasminogen to plasmin by a protease associated with the outer membrane of Escherichia coli.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6453346PubMed
6295922Chemical carcinogen-mouse mammary tumor virus interactions in cell transformation.In Vitro1983https://conductscience.org/library/papers/6295922PubMed
6246527Protease-activated "prodrugs" for cancer chemotherapy.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6246527PubMed
3008561In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor.Am J Pathol1986https://conductscience.org/library/papers/3008561PubMed
1493583An evaluation of three pesticides: piritione, supercypermethrin and metolachlor in transformation bioassays of BHK21 and hamster embryo cells.Cell Biol Toxicol1992https://conductscience.org/library/papers/1493583PubMed
492323Tumour promoters enhance anchorage-independent growth of adenovirus-transformed cells without altering the integration pattern of viral sequences.Nature1979https://conductscience.org/library/papers/492323PubMed
486316Correlation of in vitro transformation with in vivo tumorigenicity in 10T1/2 mouse cells exposed to UV light.Br J Cancer1979https://conductscience.org/library/papers/486316PubMed
284417Chemical carcinogens produce mutations to ouabain resistance in transformable C3H/10T1/2 Cl 8 mouse fibroblasts.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/284417PubMed
278986Evidence for the progressive nature of neoplastic transformation in vitro.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/278986PubMed
225525Neoplastic transformation of cultured Syrian hamster embryo cells by DNA of herpes simplex virus type 2.J Virol1979https://conductscience.org/library/papers/225525PubMed
156038Plasminogen activation transforms the morphology of quiescent 3T3 cell monolayers and initiates growth.Br J Cancer1979https://conductscience.org/library/papers/156038PubMed
150600Relationship between somatic mutation and neoplastic transformation.Proc Natl Acad Sci U S A1978https://conductscience.org/library/papers/150600PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/908023

GET https://conductscience.org/api/papers/v1/908023/authors